| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,873 |
5,962 |
$249K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,626 |
4,354 |
$79K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,990 |
2,863 |
$57K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
915 |
913 |
$49K |
| 92587 |
|
2,183 |
2,082 |
$45K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
839 |
838 |
$40K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
508 |
506 |
$28K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
447 |
435 |
$21K |
| 99442 |
|
1,230 |
1,065 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,205 |
1,153 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
414 |
375 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
893 |
444 |
$9K |
| 90461 |
|
725 |
717 |
$8K |
| 99173 |
|
1,838 |
1,661 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
47 |
45 |
$2K |
| 3008F |
|
186 |
185 |
$2K |
| 90686 |
|
202 |
201 |
$2K |
| 90619 |
|
12 |
12 |
$1K |
| 90688 |
|
81 |
81 |
$746.22 |
| 90656 |
|
43 |
43 |
$514.79 |
| 92558 |
|
91 |
91 |
$355.04 |
| 99072 |
|
64 |
60 |
$0.00 |